Should I Buy BMY Stock in 2026?
Data-driven analysis and honest assessment for Bristol-Myers Squibb Company
Current Price: $57.73P/E: 17.5
Decision Score
Hold
Based on 6 fundamental factors
Score Breakdown:
Reasonable P/E of 17.5
Growth data limited
Profitability data limited
Financial health data limited
Cash flow data limited
No recent insider activity
Key Investment Metrics
Current Price
$57.73
P/E Ratio
17.49
Revenue Growth
N/A
Profit Margin
N/A
Market Cap
$95.4B
Dividend Yield
5.36%
How BMY Compares to Competitors
Understanding how BMY stacks up against peers helps inform your investment decision.
How BMY Compares to Peers
Upcoming Events for BMY
+5 Reasons TO Buy BMY
1. Attractive dividend yield of 5.4%
strongDividend yield above 3% provides meaningful income and signals management confidence.
-5 Reasons NOT to Buy BMY
1. Minimal revenue growth
low riskGrowth of 0.0% barely keeps pace with inflation.
Who Should Buy BMY?
Investment Profile
Risk Level
Medium
Recommended Holding Period
1-3 years or long-term income
Best For:
- ✓
Income Investors
5.4% yield provides regular income
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
Consider These Alternatives
If you're interested in BMY, compare these Healthcare peers:
Pro tip: Compare BMY directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for BMY
Frequently Asked Questions
What is BMY stock price today?
BMY (Bristol-Myers Squibb Company) stock is trading at $57.73 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is BMY stock going up or down today?
BMY stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy BMY stock now?
The decision to buy BMY depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is BMY a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for BMY based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is BMY stock overvalued or undervalued?
BMY currently trades at a P/E ratio of 17.49 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if BMY is fairly priced.
What is BMY's P/E ratio?
BMY has a price-to-earnings (P/E) ratio of 17.49, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is BMY's market cap?
BMY (Bristol-Myers Squibb Company) has a market capitalization of $95.36 billion, making it a mid-cap stock.
What is BMY's price to book ratio?
Price-to-book ratio for BMY is available on our dashboard along with other valuation metrics.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Bristol-Myers Squibb Company
Full Stock Analysis
Complete BMY overview with charts and data
Is BMY Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how BMY stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Bristol-Myers Squibb Company
Complete BMY Analysis
Compare BMY With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.